Veterinary Medicines

Amoxitab 50 mg tablets for dogs and cats

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Amoxitab 50 mg tablets for dogs and cats
Amoxitab 50 mg Tabletten für Hunde und Katzen
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    57.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID9) 90 Tablet: unspecified outer container with 9 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID8) 80 Tablet: unspecified outer container with 8 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID7) 70 Tablet: unspecified outer container with 7 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID6) 60 Tablet: unspecified outer container with 6 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID5) 50 Tablet: unspecified outer container with 5 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID4) 40 Tablet: unspecified outer container with 4 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID3) 30 Tablet: unspecified outer container with 3 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID2) 20 Tablet: unspecified outer container with 2 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID13) 100 Tablet: unspecified outer container with 10 unspecified outer container each with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID12) 500 Tablet: unspecified outer container with 50 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID11) 250 Tablet: unspecified outer container with 25 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID10) 100 Tablet: unspecified outer container with 10 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402365.00.00
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0177/001
Concerned member states:
  • Sweden

Documents

Combined File of all Documents

English (PDF)
Published on: 18/12/2024
Download
German (PDF)
Published on: 18/12/2024
Download

2402365-paren-20161011.rtf

English (RTF)
Published on: 18/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."